US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Inspira Technologies Oxy B H N Ltd (IINN)
Inspira Technologies Oxy B H N Ltd (IINN) ニュース

IINN

Inspira Technologies Oxy... (IINN)

Inspira Technologies Oxy B H N Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IINN

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/05	21 : 30	PR Newswire (US)	Inspira™ to Exhibit the FDA Cleared INSPIRA™ ART100 System at a World-Renowned Event in the Sector	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/05/30	21 : 30	PR Newswire (US)	Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/05/28	22 : 25	PR Newswire (US)	INSPIRA™ ART100 Receives FDA 510(k) Clearance	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/05/02	22 : 18	PR Newswire (US)	Inspira™ Announces Start of Production of the INSPIRA™ ART100	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/04/25	21 : 00	PR Newswire (US)	Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/04/16	21 : 42	PR Newswire (US)	Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/04/10	21 : 24	PR Newswire (US)	Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/04/03	21 : 30	PR Newswire (US)	Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/04/01	21 : 00	PR Newswire (US)	Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/03/25	22 : 20	PR Newswire (US)	Inspira™ Technologies Reports Full Year 2023 Financial Results	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/03/18	20 : 00	PR Newswire (US)	Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/03/12	21 : 00	PR Newswire (US)	Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/03/09	06 : 01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/03/05	06 : 01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/03/04	23 : 25	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/03/04	23 : 20	PR Newswire (US)	Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/27	21 : 15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/27	21 : 02	PR Newswire (US)	Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/27	21 : 00	PR Newswire (US)	Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/22	23 : 18	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/22	21 : 00	PR Newswire (US)	Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologies	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/14	23 : 18	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/14	21 : 30	PR Newswire (US)	Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/13	06 : 05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/13	06 : 05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/08	23 : 15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/08	23 : 00	PR Newswire (US)	Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART Device	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/01/30	22 : 40	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/01/30	22 : 30	PR Newswire (US)	Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/01/09	23 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd

Showing the most relevant articles for your search:NASDAQ:IINN

1 2 3 4 5 6 7 次へ >>

Financial Select Sector

Health Care Select Sector

American Express

US Dollar vs Euro

Verizon Communications

Energy Select Sector SPDR

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約